NASONEX
Google image searchProduct monograph
Active ingredient
mometasone furoate, 50 MCG/ACT
DIN: 02238465
Dosage form(s): SPRAY, METERED DOSE
Route(s) of administration: NASAL
Schedule: Prescription
Company: ORGANON CANADA INC.
Date: 14-APR-2022
ATC:
- R01 — NASAL PREPARATIONS (ATC, ATC/DDD, )
- R01A — DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE (ATC, ATC/DDD)
- R01AD — Corticosteroids (ATC, ATC/DDD)
- R01AD09 — MOMETASONE (ATC/DDD)
Reference brand drug: Nasonex
